全球空静脉 (IV) 袋市场 – 行业趋势及 2031 年预测

空静脉输液袋市场分析及规模

在兽医学中，空静脉 (IV) 袋是给动物输液、输药和其他治疗的重要工具。兽医依靠静脉输液袋来补充水分、输送药物，并在动物手术、急救和医疗治疗期间支持重症护理干预。这些袋子有各种尺寸和配置，以适应不同的动物种类和治疗要求。无论是用于猫和狗等小型伴侣动物，还是用于马和牛等大型牲畜，静脉输液袋在兽医医疗保健中都发挥着至关重要的作用，可确保准确剂量和安全地输送静脉治疗。

2023 年全球空静脉 (IV) 袋市场规模价值 39.1 亿美元，预计到 2031 年将达到 59.6 亿美元，2024 年至 2031 年预测期内的复合年增长率为 5.40%。

除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察之外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

报告范围和市场细分       

市场定义

Empty intravenous (IV) bags refer to medical containers designed to hold various intravenous fluids, such as saline solution or medications, but are devoid of content. They are typically made of flexible plastic and come in various sizes to accommodate different volumes of fluids. These bags are crucial in healthcare settings for administering treatments directly into the bloodstream. Once filled with the required solution or medication, they are connected to IV lines and used for intravenous therapy, transfusions, or hydration. Empty IV bags are sterile and disposable, ensuring patient safety and hygiene during medical procedures.

Empty Intravenous (IV) Bags Market Dynamics

Drivers                                                                                          

• Rising Prevalence of Chronic Diseases

Chronic diseases such as cancer, diabetes, and cardiovascular disorders often require ongoing intravenous therapies for medication administration, hydration, and nutritional support. As the incidence of chronic diseases continues to increase due to factors such as aging populations, sedentary lifestyles, and unhealthy dietary habits, the need for IV bags for disease management and treatment escalates. Healthcare facilities, including hospitals, clinics, and home healthcare settings, require a consistent supply of IV bags to meet the growing demand for intravenous treatments.

• Increasing Technological Innovations in IV Bags

Advancements such as the development of more durable and flexible materials, improved closure systems to maintain sterility, and enhanced compatibility with various medications contribute to the market growth. Features such as integrated ports for easy access and administration of medications, as well as compatibility with infusion pumps and other medical devices, enhance the usability and efficiency of IV bags, driving their adoption in healthcare settings.

Opportunities

• Expansion of Home Healthcare Services

As healthcare shifts towards decentralized models and patients seek alternatives to traditional hospital stays, there's a rising demand for IV bags to facilitate intravenous therapies in the comfort of patients' homes. Home healthcare services offer convenience and cost-effectiveness for managing chronic conditions, post-operative care, and palliative treatments, driving the need for IV bags for fluid administration, medication delivery, and nutritional support outside clinical settings. This trend empowers patients to take greater control of their healthcare and creates a growing market for IV bags tailored for home use, with features emphasizing ease of use, portability, and safety.

• Rising Government Initiatives

Governments often invest in healthcare infrastructure, including hospitals and clinics, which increases the demand for IV bags for fluid administration during treatments and surgeries. Favorable reimbursement policies for intravenous therapies incentivize healthcare providers to utilize IV bags, boosting market growth. Government initiatives also focus on regulating the quality and safety standards of medical devices, including IV bags, ensuring their compliance with stringent regulations, which further stimulates market demand. Awareness campaigns and educational programs sponsored by governments raise awareness among healthcare professionals and patients about the importance of intravenous therapy, fostering the adoption of IV bags in clinical settings.

Restraints/Challenges

• High Concerns Regarding Plastic Pollution

As the healthcare industry increasingly recognizes the environmental impact of single-use plastics, there is growing pressure to seek alternative, more sustainable packaging solutions. The substantial use of plastic IV bags contributes to plastic waste generation, raising environmental concerns and prompting healthcare facilities to explore eco-friendly alternatives. Moreover, public awareness campaigns and regulatory initiatives aimed at reducing plastic consumption may lead to shifts in consumer preferences towards greener packaging options, potentially impacting the demand for traditional plastic IV bags.

• High Volatility in Raw Material Prices

Fluctuations in the prices of key materials, such as plastic resins, which are integral to IV bag manufacturing, can directly impact production costs. Manufacturers may face challenges in maintaining stable pricing for IV bags, leading to uncertainty for both producers and consumers. Sudden spikes in raw material prices can squeeze profit margins and hinder investment in innovation or expansion initiatives within the industry.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In February 2023, Bowmed Ibisqus Company launched Levofloxacin fluid bags in a ready-to-use format, wrapped with foil to shield the fluid from light. This innovation not only addressed the need for convenient IV solutions but also potentially impacted the demand for empty IV bags in the market as hospitals and healthcare facilities transitioned to this new format
• 2022 年 1 月，美国 FDA 批准了 B. Braun Medical Inc. 位于佛罗里达州代托纳比奇的新制药生产设施。该设施指定生产 500 毫升和 1,000 毫升 Excel Plus 静脉输液袋（含 0.9% 氯化钠），可能导致市场上出现空静脉输液袋供应不足的情况。
• 2021 年 4 月，Winpak Ltd. 和 Wipak Walothen GmbH 合作成立 Wiicare，这是一个专注于提供医疗保健包装解决方案（包括医用液体容器）的品牌。此次合作旨在满足医疗行业对创新包装解决方案日益增长的需求，可能会影响空静脉 (IV) 袋市场

空静脉输液袋市场范围

市场根据类型和产品类型进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

类型

• PVC
• 非 PVC

产品类型

• 单室
• 多室

空静脉 (IV) 袋市场区域分析/见解

对市场进行分析，并按上述国家、类型和产品类型提供市场规模洞察和趋势。

市场报告涉及的国家包括美国、加拿大、墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、沙特阿拉伯、阿联酋、南非、埃及、以色列、巴西和阿根廷。

北美占据市场主导地位，主要原因是该地区广泛采用非 PVC 袋。这一趋势受到创新医疗技术日益普及的推动。因此，预计整个预测期内北美对空 IV 袋的需求将继续上升。该地区积极拥抱医疗保健领域的进步，包括更安全、更环保的包装解决方案，进一步推动了该地区空 IV 袋市场的增长轨迹。

受多种因素推动，亚太地区市场预计将出现大幅增长。这些因素包括疾病高发，尤其是老龄化人口，以及更好的报销政策和不断增加的投资以改善医疗基础设施。此外，不健康饮食习惯的增加也导致对医疗干预（包括静脉注射疗法）的需求不断增加。然而，尽管存在这些增长动力，但医疗保健意识低下等挑战仍然存在，影响了该地区的市场动态。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

该市场还为您提供每个国家/地区资本设备医疗支出增长、市场上不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对市场的影响的详细市场分析。数据适用于 2016-2021 年的历史时期。

竞争格局和空静脉输液袋市场分析

市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对市场的关注有关。

市场上的一些主要参与者包括：

• Sippex 静脉输液袋（美国）
• Technoflex (日本)
• Wipak集团（德国）
• 百特（美国）
• B. Braun（德国）
• ICU Medical, Inc.（美国）
• POLYCINE GmbH（德国）
• RENOLIT SE (德国)
• 辉瑞公司（美国）
• West Pharmaceutical Services Inc.（美国）
• 济南友力实业有限公司 (中国)
• 江苏懿阳医疗器械有限公司 (中国)

SKU-68243